Andrew H. Ko

MD

Colorectal and gastrointestinal cancer specialist
East Coast transplant and lover of piano, singing and sports

Dr. Andrew H. Ko is a specialist in colorectal and gastrointestinal cancers, with a particular focus on pancreatic cancer. He is interested in the development of new treatment strategies, including molecularly targeted therapies, which block cancer cell activity by interfering with specific molecules.

Ko earned an undergraduate degree in applied mathematics and biology at Brown University. He earned his medical degree at the Johns Hopkins School of Medicine. After a residency at Beth Israel Deaconess Medical Center, he completed a fellowship in medical oncology at Stanford University. He joined UCSF in 2001.

  • Education

    Johns Hopkins University, 1995

  • Residencies

    Beth Israel Hospital-Boston, MA, Internal Medicine, 1998

  • Fellowships

    Stanford University Medical Center, 2001

  • Board Certifications

    Medical Oncology, American Board of Internal Medicine

  • Academic Title

    Professor

I am honored to partner with patients as I provide compassionate, thoughtful and cutting-edge care during a challenging time in their lives.

Conditions I specialize in

Clinics I work with

View map

Gastrointestinal Medical Oncology Clinic

Bakar Precision Cancer Medicine Building

1825 Fourth St., Fourth Floor
San Francisco, CA 94158

(415) 353-9888
M-F, 8 a.m. - 5 p.m.

Pancreas Center

Bakar Precision Cancer Medicine Building

1825 Fourth St., Fourth Floor
San Francisco, CA 94158

(415) 353-9888
M-F, 8 a.m. - 5 p.m.

My reviews

4.9

Overall Experience
182 Reviews
My family and I were very impressed with Dr. Ko. He managed to demonstrate his expertise while projecting a very caring attitude at the same time.
Explained things in a way that was easy to understand
181 Reviews
Did the doctor pay attention to your concerns
181 Reviews
Gave easy to understand instructions about taking care of health problems or concerns
179 Reviews
Knew the important information about your medical history
182 Reviews
The provider showed respect for what you had to say
181 Reviews
The provider spent enough time with me
181 Reviews
Read all reviews About our process

Selected research

Decorative Caduceus

A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer

Overall survival (OS) is defined from the time of initiation of treatment until death due to any cause. Subjects still alive at the time of an analysis will be considered censored at their date of last contact.

Recruiting

Decorative Caduceus

APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction ...

Adverse events will be summarized by presenting, at each dose level, the number and percentage of patients having any adverse event, having an adverse event in each body system and having each individual adverse event. If no patie...

Recruiting

Contact me

Providers on my team

Share